Radiology and Oncology (Jan 2019)
Potential of osteopontin in the management of epithelial ovarian cancer
Abstract
Osteopontin (sOPN) is a promising blood tumour marker for detecting epithelial ovarian cancer (EOC). However, other clinical uses of sOPN as a tumour marker in EOC are still lacking. Since sOPN concentrations in serum are not associated with those in ascites, we compared clinical value of sOPN concentrations in the two body fluids.
Keywords